Euronext NvEURONEXT: ENX

Da oggi OPT su Euronext

· MarketScreener
Da oggi OPT su Euronext
  • Trentacinquesima ammissione su Euronext nel 2026
  • La società ha raccolto €2 milioni
  • La capitalizzazione di mercato all'IPO è pari a €5,3 milioni

Milan - 26 June 2026 - Euronext today congratulates OPT on its listing on Euronext Growth Milan.

OPT designs and delivers high-value services for healthcare (Healthcare High Value-Added Services, or HHVAS), in the clinical and organisational field, aimed at both public and private healthcare systems, and sponsored by pharmaceutical companies.

The listing of OPT represents Euronext's 35th listing this year. In the placement phase, OPT raised €2 million including the potential exercise of the over-allotment option. Excluding the exercise of the over-allotment option, the total amount raised will be €1.8 million.

The free float at the time of admission is 33.68%, and the market capitalisation at IPO amounts to €5.3 million (€5.5 million, assuming the full exercise of the over-allotment option).

Davide Lucano, Chief Executive Officer of OPT, said: "Healthcare High Value-Added Services are becoming an increasingly important component in the evolution of modern healthcare systems, as they enable the structured integration of the needs of various stakeholders, including hospitals, pharmaceutical and medtech companies, patients, and institutions, throughout the entire care journey. Our work focuses precisely on this intersection: supporting the implementation of more efficient clinical and organisational models, promoting the appropriate adoption of therapies, enhancing the monitoring capabilities of care pathways, and contributing to the generation of evidence that is valuable to all stakeholders involved. In this context, OPT acts as an operational partner to the healthcare system, with the goal of making care pathways more coordinated, measurable, and sustainable, while simultaneously improving the patient experience and the overall quality of care."

Giuliano Rizzi, membro del CDA di OPT, Oreste Pitocchi, fondatore di OPT, Davide Lucano, Amministratore Delegato di OPT e Giacomo Andreoli, Presidente del CDA di OPT

CONTACTS

ANALYSTS & INVESTORS -ir@euronext.com
Investor Relations Judith Stein +33 6 15 23 91 97
Margaux Kurver +33 6 84 16 85 03
MEDIA -mediateam@euronext.com
Europe Andrea Monzani +33 1 7048 24 45
Sandra Machado +351 917 776 897
Belgium Marianne Aalders +32 26 20 15 01
France, Corporate Flavio Bornancin-Tomasella +33 1 70 48 24 45
Greece Ioulia Zafolia +30 694 570 1070
Ireland Catalina Augspach +39 02 72 42 62 13
Italy Ester Russom +39 02 72 42 67 56
The Netherlands Marianne Aalders +31 20 721 41 33
Norway Cathrine Lorvik Segerlund +47 41 69 59 10
Portugal Sandra Machado +351 91 777 68 97
Scarica il comunicato stampa